This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sriuranpong, V. Articles by Gutkind, J. S. Search for Related Content PubMed PubMed Citation Articles by Sriuranpong, V. Articles by Gutkind, J. S.

Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays

¹ Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, and ² Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland; ³ Medical Oncology Unit, Department of Medicine, ⁴ Genetics Unit, Department of Anatomy, and ⁵ Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; and ⁶ Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

ABSTRACT

A number of genetic and epigenetic changes underlying the development of nasopharyngeal carcinomas have recently been identified. However, there is still limited information on the nature of the genes and gene products whose aberrant expression and activity promote the malignant conversion of nasopharyngeal epithelium. Here, we have performed a genome-wide transcriptome analysis by probing cDNA microarrays with fluorescent-labeled amplified RNA derived from laser capture microdissected cells procured from normal nasopharyngeal epithelium and areas of metaplasia-dysplasia and carcinoma from EBV-associated nasopharyngeal carcinomas. This approach enabled the identification of genes differentially expressed in each cell population, as well as numerous genes whose expression can help explain the aggressive clinical nature of this tumor type. For example, genes indicating cell cycle aberrations (cyclin D2, cyclin B1, activator of S-phase kinase, and the cell cycle checkpoint kinase, CHK1) and invasive-metastatic potential (matrix metalloproteinase 11, v-Ral, and integrin ß₄) were highly expressed in tumor cells. In contrast, genes underexpressed in tumors included genes involved in apoptosis (B-cell CLL/lymphoma 6, secretory leukocyte protease inhibitor, and calpastatin), cell structure (keratin 7 and carcinoembryonic antigen-related cell adhesion molecule 6), and putative tumor suppressor genes (H-Ras-like suppressor 3, retinoic acid receptor responder 1, and growth arrested specific 8) among others. Gene expression patterns also suggested alterations in the Wnt/ß-catenin and transforming growth factor ß pathways in nasopharyngeal carcinoma. Thus, expression profiles indicate that aberrant expression of growth, survival, and invasion-promoting genes may contribute to the molecular pathogenesis of nasopharyngeal carcinoma. Ultimately, this approach may facilitate the identification of clinical useful markers of disease progression and novel potential therapeutic targets for nasopharyngeal carcinoma.

This article has been cited by other articles:

				J. G. Lyons, V. Patel, N. C. Roue, S. Y. Fok, L. L. Soon, G. M. Halliday, and J. S. Gutkind Snail Up-regulates Proinflammatory Mediators and Inhibits Differentiation in Oral Keratinocytes Cancer Res., June 15, 2008; 68(12): 4525 - 4530. [Abstract] [Full Text] [PDF]

				A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al. Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445. [Abstract] [Full Text] [PDF]

				T. L. Lee, X. P. Yang, B. Yan, J. Friedman, P. Duggal, L. Bagain, G. Dong, N. T. Yeh, J. Wang, J. Zhou, et al. A Novel Nuclear Factor-{kappa}B Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status Clin. Cancer Res., October 1, 2007; 13(19): 5680 - 5691. [Abstract] [Full Text] [PDF]

				Z. A. Felton-Edkins, A. Kondrashov, D. Karali, J. A. Fairley, C. W. Dawson, J. R. Arrand, L. S. Young, and R. J. White Epstein-Barr Virus Induces Cellular Transcription Factors to Allow Active Expression of EBER Genes by RNA Polymerase III J. Biol. Chem., November 10, 2006; 281(45): 33871 - 33880. [Abstract] [Full Text] [PDF]

				B. Ma and A. Chan Transcriptional profiling of tumor biopsies in oncology trials--a 'window' of opportunity for evaluating new drugs in nasopharyngeal cancer? Ann. Onc., November 1, 2006; 17(11): 1611 - 1613. [Full Text] [PDF]

				E. T. Chang and H.-O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1765 - 1777. [Abstract] [Full Text] [PDF]

				K. W. Yip, W. Shi, M. Pintilie, J. D. Martin, J. D. Mocanu, D. Wong, C. MacMillan, P. Gullane, B. O'Sullivan, C. Bastianutto, et al. Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer. Clin. Cancer Res., October 1, 2006; 12(19): 5726 - 5732. [Abstract] [Full Text] [PDF]

				S. Sengupta, J. A. den Boon, I-H. Chen, M. A. Newton, D. B. Dahl, M. Chen, Y.-J. Cheng, W. H. Westra, C.-J. Chen, A. Hildesheim, et al. Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma Cancer Res., August 15, 2006; 66(16): 7999 - 8006. [Abstract] [Full Text] [PDF]

				C. Rosse, A. Hatzoglou, M.-C. Parrini, M. A. White, P. Chavrier, and J. Camonis RalB Mobilizes the Exocyst To Drive Cell Migration Mol. Cell. Biol., January 15, 2006; 26(2): 727 - 734. [Abstract] [Full Text] [PDF]

				S. J. Libertini, B. S. Robinson, N. K. Dhillon, D. Glick, M. George, S. Dandekar, J. P. Gregg, E. Sawai, and M. Mudryj Cyclin E Both Regulates and Is Regulated by Calpain 2, a Protease Associated with Metastatic Breast Cancer Phenotype Cancer Res., December 1, 2005; 65(23): 10700 - 10708. [Abstract] [Full Text] [PDF]